Business News • PR NewsWire • Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies

Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies

Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies

IRVING, Texas, March 29, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the presentation of important study data showing the presence of PD-1 and PD-L1 expressing cells in 1,599 gynecologic cancer samples. Using Caris Molecular Intelligence®, the company's panomic...

View More : http://www.prnewswire.com/news-releases/caris-life-sciences-multiplatform-tumor-profiling-technology-identifies-expressi...

Releted News by prnewswire

Magna veröffentlicht Jahresbericht 2014

Magna publie son rapport annuel de gestion pour l'exercice 2014

Taj Group Announces Opening of Taj Dubai

Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies

Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer

Offering Hospitality to Thai Tourists in Thai Language: "Yokohama Official Visitors' Guide" Website Ready for Use